Spyre Therapeutics (SYRE) Stock Chart & Stock Price History $22.68 -0.59 (-2.54%) Closing price 04:00 PM EasternExtended Trading$22.69 +0.01 (+0.04%) As of 05:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Spyre Therapeutics Stock Price Performance 5 Day Performance+0.13%1 Month Performance+5.24%3 Month Performance-31.23%6 Month Performance-10.32%Year-To-Date Performance-2.58%1 Year Performance+0.96% Receive SYRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Spyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address SYRE Stock Chart for Thursday, February, 13, 2025 SYRE Chart by TradingView Spyre Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/13/2025$23.27$22.68-2.54%$23.75$22.57509,443 shs$1.17 billion02/12/2025$22.15$23.27+5.06%$23.35$21.13467,868 shs$1.20 billion02/11/2025$22.75$22.15-2.64%$22.75$21.90993,051 shs$1.14 billion02/10/2025$22.65$22.75+0.44%$23.00$22.11709,262 shs$1.17 billion02/07/2025$23.86$22.65-5.07%$24.39$22.44682,957 shs$1.16 billion02/06/2025$23.56$23.86+1.27%$24.35$23.42477,741 shs$1.23 billion02/05/2025$23.70$23.56-0.59%$24.83$23.41405,297 shs$1.21 billion02/04/2025$22.90$23.70+3.49%$23.84$22.60645,349 shs$1.22 billion02/03/2025$22.99$22.90-0.39%$23.68$21.67508,624 shs$1.18 billion01/31/2025$22.27$22.99+3.23%$23.59$22.25557,455 shs$1.18 billion Get the Latest News and Ratings for SYRE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Spyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 01/30/2025$21.90$22.27+1.69%$22.74$21.791.24 million shs$1.15 billion01/29/2025$21.79$21.90+0.50%$22.18$21.35330,139 shs$1.13 billion01/28/2025$20.82$21.79+4.66%$22.00$20.25533,004 shs$1.12 billion01/27/2025$21.60$20.82-3.61%$22.81$20.66501,573 shs$1.07 billion01/24/2025$21.81$21.60-0.96%$22.44$21.00437,241 shs$1.11 billion01/23/2025$21.82$21.81-0.05%$22.05$21.01532,132 shs$1.12 billion01/22/2025$22.28$21.82-2.06%$22.81$21.59651,476 shs$1.12 billion01/21/2025$20.62$22.28+8.05%$22.82$20.97692,673 shs$1.15 billion01/20/2025$20.62$20.62$21.24$20.33607,576 shs$1.06 billion01/17/2025$20.55$20.62+0.34%$21.24$20.33607,576 shs$1.06 billion01/16/2025$21.66$20.55-5.12%$22.11$20.39715,277 shs$1.06 billion01/15/2025$20.80$21.66+4.13%$22.49$21.05513,870 shs$1.11 billion01/14/2025$21.55$20.80-3.48%$21.97$20.36489,686 shs$1.07 billion01/13/2025$22.46$21.55-4.05%$23.00$20.55715,627 shs$1.11 billion Related Companies KRYS Stock Chart GRFS Stock Chart RARE Stock Chart ADMA Stock Chart PTCT Stock Chart OGN Stock Chart BHVN Stock Chart RNA Stock Chart AKRO Stock Chart SRRK Stock Chart Receive SYRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Spyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SYRE) was last updated on 2/13/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spyre Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spyre Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
